Clinical Applications of Molecular Biomarkers in Prostate Cancer

There is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological diversity has had only a minimal impact on clinical practice. Treatment outcomes in patients with localised PCa are often highly variable, even among patients stratified to the same risk group or disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Couñago, Felipe, López-Campos, Fernando, Díaz-Gavela, Ana Aurora, Almagro, Elena, Fenández-Pascual, Esaú, Henríquez, Iván, Lozano, Rebeca, Linares Espinós, Estefanía, Gómez-Iturriaga, Alfonso, de Velasco, Guillermo, Quintana Franco, Luis Miguel, Rodríguez-Melcón, Ignacio, López-Torrecilla, José, Spratt, Daniel E., Guerrero, Luis Leonardo, Martínez-Salamanca, Juan Ignacio, del Cerro, Elia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352850/
https://www.ncbi.nlm.nih.gov/pubmed/32545454
http://dx.doi.org/10.3390/cancers12061550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352850/
https://www.ncbi.nlm.nih.gov/pubmed/32545454
http://dx.doi.org/10.3390/cancers12061550

Ejemplares similares